Industry Research Reports
Home > Reports > Service & Software > Global Canine Tumor Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Canine Tumor Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Service & Software
Published Date: 2025-09-06
Pages: 80 Pages
Report ld: 4957395
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Canine Tumor Screening Market Size(US$)
CAGR 2025-2031
6.5%
Market Size,2031
USD 635
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 435 million
Market Forecast in 2031(Value)
US$ 635 million
CAGR
6.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Canine Tumor Screening market size was US$ 411 million in 2024 and is forecast to a readjusted size of US$ 635 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Canine liquid biopsy is a method of analyzing biomarkers in body fluids (such as blood, urine or saliva) to detect the presence of cancer or monitor the progression of cancer. Unlike traditional tissue biopsies, liquid biopsies are non-invasive, fast and convenient. By obtaining a small blood sample, doctors can analyze free DNA, circulating tumor cells, exosomes, etc. to obtain information about the tumor.
The North America Canine Tumor Screening market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key players of Canine Tumor Screening include PetDx, CYTOGEN, BioChain, Small Door, ANGLE, BioChain Institute Inc., CANCAN DIAGNOSTICS., etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Canine Tumor Screening market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- PetDx
- CYTOGEN
- BioChain
- Small Door
- ANGLE
- BioChain Institute Inc.
- CANCAN DIAGNOSTICS.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cut Biopsy
- Needle Biopsy
Segment by Application
- Pet Hospital
- Clinic
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Canine Tumor Screening market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Needle Biopsy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinic in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Canine Tumor Screening value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Cut Biopsy
1.2.3 Needle Biopsy
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Pet Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Tumor Screening Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Canine Tumor Screening Revenue Market Share by Region (2020-2025)
2.4 Global Canine Tumor Screening Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Canine Tumor Screening Market Size and Prospective (2020-2031)
2.5.2 Europe Canine Tumor Screening Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Canine Tumor Screening Market Size and Prospective (2020-2031)
2.5.4 Latin America Canine Tumor Screening Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa Canine Tumor Screening Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Canine Tumor Screening Historic Market Size by Type (2020-2025)
3.2 Global Canine Tumor Screening Forecasted Market Size by Type (2026-2031)
3.3 Different Types Canine Tumor Screening Representative Players
4 Breakdown Data by Application
4.1 Global Canine Tumor Screening Historic Market Size by Application (2020-2025)
4.2 Global Canine Tumor Screening Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Canine Tumor Screening Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Canine Tumor Screening Players by Revenue (2020-2025)
5.1.2 Global Canine Tumor Screening Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Canine Tumor Screening Revenue
5.4 Global Canine Tumor Screening Market Concentration Analysis
5.4.1 Global Canine Tumor Screening Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Canine Tumor Screening Revenue in 2024
5.5 Global Key Players of Canine Tumor Screening Head office and Area Served
5.6 Global Key Players of Canine Tumor Screening, Product and Application
5.7 Global Key Players of Canine Tumor Screening, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Canine Tumor Screening Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Canine Tumor Screening Market Size by Type (2020-2025)
6.1.2.2 North America Canine Tumor Screening Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Canine Tumor Screening Market Size by Application (2020-2025)
6.1.3.2 North America Canine Tumor Screening Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Canine Tumor Screening Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Canine Tumor Screening Market Size by Type (2020-2025)
6.2.2.2 Europe Canine Tumor Screening Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Canine Tumor Screening Market Size by Application (2020-2025)
6.2.3.2 Europe Canine Tumor Screening Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Canine Tumor Screening Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Canine Tumor Screening Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Canine Tumor Screening Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Canine Tumor Screening Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific Canine Tumor Screening Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America Canine Tumor Screening Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Canine Tumor Screening Market Size by Type (2020-2025)
6.4.2.2 Latin America Canine Tumor Screening Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Canine Tumor Screening Market Size by Application (2020-2025)
6.4.3.2 Latin America Canine Tumor Screening Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa Canine Tumor Screening Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Canine Tumor Screening Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa Canine Tumor Screening Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Canine Tumor Screening Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa Canine Tumor Screening Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 PetDx
7.1.1 PetDx Company Details
7.1.2 PetDx Business Overview
7.1.3 PetDx Canine Tumor Screening Introduction
7.1.4 PetDx Revenue in Canine Tumor Screening Business (2020-2025)
7.1.5 PetDx Recent Development
7.2 CYTOGEN
7.2.1 CYTOGEN Company Details
7.2.2 CYTOGEN Business Overview
7.2.3 CYTOGEN Canine Tumor Screening Introduction
7.2.4 CYTOGEN Revenue in Canine Tumor Screening Business (2020-2025)
7.2.5 CYTOGEN Recent Development
7.3 BioChain
7.3.1 BioChain Company Details
7.3.2 BioChain Business Overview
7.3.3 BioChain Canine Tumor Screening Introduction
7.3.4 BioChain Revenue in Canine Tumor Screening Business (2020-2025)
7.3.5 BioChain Recent Development
7.4 Small Door
7.4.1 Small Door Company Details
7.4.2 Small Door Business Overview
7.4.3 Small Door Canine Tumor Screening Introduction
7.4.4 Small Door Revenue in Canine Tumor Screening Business (2020-2025)
7.4.5 Small Door Recent Development
7.5 ANGLE
7.5.1 ANGLE Company Details
7.5.2 ANGLE Business Overview
7.5.3 ANGLE Canine Tumor Screening Introduction
7.5.4 ANGLE Revenue in Canine Tumor Screening Business (2020-2025)
7.5.5 ANGLE Recent Development
7.6 BioChain Institute Inc.
7.6.1 BioChain Institute Inc. Company Details
7.6.2 BioChain Institute Inc. Business Overview
7.6.3 BioChain Institute Inc. Canine Tumor Screening Introduction
7.6.4 BioChain Institute Inc. Revenue in Canine Tumor Screening Business (2020-2025)
7.6.5 BioChain Institute Inc. Recent Development
7.7 CANCAN DIAGNOSTICS.
7.7.1 CANCAN DIAGNOSTICS. Company Details
7.7.2 CANCAN DIAGNOSTICS. Business Overview
7.7.3 CANCAN DIAGNOSTICS. Canine Tumor Screening Introduction
7.7.4 CANCAN DIAGNOSTICS. Revenue in Canine Tumor Screening Business (2020-2025)
7.7.5 CANCAN DIAGNOSTICS. Recent Development
8 Canine Tumor Screening Market Dynamics
8.1 Canine Tumor Screening Industry Trends
8.2 Canine Tumor Screening Market Drivers
8.3 Canine Tumor Screening Market Challenges
8.4 Canine Tumor Screening Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Canine Tumor Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Canine Tumor Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Canine Tumor Screening Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Canine Tumor Screening Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Canine Tumor Screening Revenue Share by Region (2020-2025)
Table 6. Global Canine Tumor Screening Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Canine Tumor Screening Revenue Share Forecast by Region (2026-2031)
Table 8. Global Canine Tumor Screening Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Canine Tumor Screening Revenue Market Share by Type (2020-2025)
Table 10. Global Canine Tumor Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Canine Tumor Screening Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Canine Tumor Screening Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Canine Tumor Screening Revenue Market Share by Application (2020-2025)
Table 15. Global Canine Tumor Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Canine Tumor Screening Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Canine Tumor Screening Application
Table 18. Global Canine Tumor Screening Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Canine Tumor Screening Market Share by Players (2020-2025)
Table 20. Global Top Canine Tumor Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Tumor Screening as of 2024)
Table 21. Ranking of Global Top Canine Tumor Screening Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Canine Tumor Screening Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Canine Tumor Screening, Headquarters and Area Served
Table 24. Global Key Players of Canine Tumor Screening, Product and Application
Table 25. Global Key Players of Canine Tumor Screening, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Canine Tumor Screening Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Canine Tumor Screening Revenue Market Share by Company (2020-2025)
Table 29. North America Canine Tumor Screening Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Canine Tumor Screening Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Canine Tumor Screening Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Canine Tumor Screening Revenue Market Share by Company (2020-2025)
Table 33. Europe Canine Tumor Screening Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Canine Tumor Screening Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia-Pacific Canine Tumor Screening Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia-Pacific Canine Tumor Screening Revenue Market Share by Company (2020-2025)
Table 37. Asia-Pacific Canine Tumor Screening Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia-Pacific Canine Tumor Screening Market Size by Application (2020-2025) & (US$ Million)
Table 39. Latin America Canine Tumor Screening Revenue by Company (2020-2025) & (US$ Million)
Table 40. Latin America Canine Tumor Screening Revenue Market Share by Company (2020-2025)
Table 41. Latin America Canine Tumor Screening Market Size by Type (2020-2025) & (US$ Million)
Table 42. Latin America Canine Tumor Screening Market Size by Application (2020-2025) & (US$ Million)
Table 43. Middle East & Africa Canine Tumor Screening Revenue by Company (2020-2025) & (US$ Million)
Table 44. Middle East & Africa Canine Tumor Screening Revenue Market Share by Company (2020-2025)
Table 45. Middle East & Africa Canine Tumor Screening Market Size by Type (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Canine Tumor Screening Market Size by Application (2020-2025) & (US$ Million)
Table 47. PetDx Company Details
Table 48. PetDx Business Overview
Table 49. PetDx Canine Tumor Screening Product
Table 50. PetDx Revenue in Canine Tumor Screening Business (2020-2025) & (US$ Million)
Table 51. PetDx Recent Development
Table 52. CYTOGEN Company Details
Table 53. CYTOGEN Business Overview
Table 54. CYTOGEN Canine Tumor Screening Product
Table 55. CYTOGEN Revenue in Canine Tumor Screening Business (2020-2025) & (US$ Million)
Table 56. CYTOGEN Recent Development
Table 57. BioChain Company Details
Table 58. BioChain Business Overview
Table 59. BioChain Canine Tumor Screening Product
Table 60. BioChain Revenue in Canine Tumor Screening Business (2020-2025) & (US$ Million)
Table 61. BioChain Recent Development
Table 62. Small Door Company Details
Table 63. Small Door Business Overview
Table 64. Small Door Canine Tumor Screening Product
Table 65. Small Door Revenue in Canine Tumor Screening Business (2020-2025) & (US$ Million)
Table 66. Small Door Recent Development
Table 67. ANGLE Company Details
Table 68. ANGLE Business Overview
Table 69. ANGLE Canine Tumor Screening Product
Table 70. ANGLE Revenue in Canine Tumor Screening Business (2020-2025) & (US$ Million)
Table 71. ANGLE Recent Development
Table 72. BioChain Institute Inc. Company Details
Table 73. BioChain Institute Inc. Business Overview
Table 74. BioChain Institute Inc. Canine Tumor Screening Product
Table 75. BioChain Institute Inc. Revenue in Canine Tumor Screening Business (2020-2025) & (US$ Million)
Table 76. BioChain Institute Inc. Recent Development
Table 77. CANCAN DIAGNOSTICS. Company Details
Table 78. CANCAN DIAGNOSTICS. Business Overview
Table 79. CANCAN DIAGNOSTICS. Canine Tumor Screening Product
Table 80. CANCAN DIAGNOSTICS. Revenue in Canine Tumor Screening Business (2020-2025) & (US$ Million)
Table 81. CANCAN DIAGNOSTICS. Recent Development
Table 82. Canine Tumor Screening Market Trends
Table 83. Canine Tumor Screening Market Drivers
Table 84. Canine Tumor Screening Market Challenges
Table 85. Canine Tumor Screening Market Restraints
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Canine Tumor Screening Product Picture
Figure 2. Global Canine Tumor Screening Market Share by Type: 2024 VS 2031
Figure 3. Cut Biopsy Features
Figure 4. Needle Biopsy Features
Figure 5. Global Canine Tumor Screening Market Share by Application: 2024 VS 2031
Figure 6. Pet Hospital
Figure 7. Clinic
Figure 8. Canine Tumor Screening Report Years Considered
Figure 9. Global Canine Tumor Screening Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 10. Global Canine Tumor Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Canine Tumor Screening Revenue Market Share by Region: 2020 VS 2024
Figure 12. North America Canine Tumor Screening Revenue (US$ Million) Growth Rate (2020-2031)
Figure 13. Europe Canine Tumor Screening Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Asia-Pacific Canine Tumor Screening Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Latin America Canine Tumor Screening Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Middle East & Africa Canine Tumor Screening Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Global Canine Tumor Screening Market Share by Players in 2024
Figure 18. Global Top Canine Tumor Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Tumor Screening as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Canine Tumor Screening Revenue in 2024
Figure 20. North America Canine Tumor Screening Market Share by Type (2020-2025)
Figure 21. North America Canine Tumor Screening Market Share by Application (2020-2025)
Figure 22. Europe Canine Tumor Screening Market Share by Type (2020-2025)
Figure 23. Europe Canine Tumor Screening Market Share by Application (2020-2025)
Figure 24. Asia-Pacific Canine Tumor Screening Market Share by Type (2020-2025)
Figure 25. Asia-Pacific Canine Tumor Screening Market Share by Application (2020-2025)
Figure 26. Latin America Canine Tumor Screening Market Share by Type (2020-2025)
Figure 27. Latin America Canine Tumor Screening Market Share by Application (2020-2025)
Figure 28. Middle East & Africa Canine Tumor Screening Market Share by Type (2020-2025)
Figure 29. Middle East & Africa Canine Tumor Screening Market Share by Application (2020-2025)
Figure 30. PetDx Revenue Growth Rate in Canine Tumor Screening Business (2020-2025)
Figure 31. CYTOGEN Revenue Growth Rate in Canine Tumor Screening Business (2020-2025)
Figure 32. BioChain Revenue Growth Rate in Canine Tumor Screening Business (2020-2025)
Figure 33. Small Door Revenue Growth Rate in Canine Tumor Screening Business (2020-2025)
Figure 34. ANGLE Revenue Growth Rate in Canine Tumor Screening Business (2020-2025)
Figure 35. BioChain Institute Inc. Revenue Growth Rate in Canine Tumor Screening Business (2020-2025)
Figure 36. CANCAN DIAGNOSTICS. Revenue Growth Rate in Canine Tumor Screening Business (2020-2025)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 6.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Canine Tumor Screening market?
What was the global market size of Canine Tumor Screening in 2025?
What was the global market size of Canine Tumor Screening in 2031?
What is the annual compound growth rate of the global Canine Tumor Screening market size from 2025 to 2031?
Related Reports
Global Canine Tumor Screening Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Canine Tumor Screening market is projected to grow from US$ 435 million in 2025 to US$ 672 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 120
USD 4900.00
(Single User License)
Global Canine Tumor Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Canine Tumor Screening market size was US$ 435 million in 2025 and is forecast to reach a readjusted size of US$ 672 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 80
USD 4250.00
(Single User License)
Global Canine Tumor Screening Market Research Report 2026
The global Canine Tumor Screening market was valued at US$ 435 million in 2025 and is anticipated to reach US$ 672 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 104
USD 2900.00
(Single User License)
Canine Tumor Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Canine Tumor Screening was estimated to be worth US$ 435 million in 2025 and is projected to reach US$ 672 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 97
USD 3950.00
(Single User License)
Global Canine Tumor Screening Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Canine Tumor Screening market is projected to grow from US$ 411 million in 2024 to US$ 635 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 127
USD 4900.00
(Single User License)
Canine Tumor Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Canine Tumor Screening was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 635 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 97
USD 3950.00
(Single User License)
Global Canine Tumor Screening Market Research Report 2025
The global market for Canine Tumor Screening was valued at US$ 411 million in the year 2024 and is projected to reach a revised size of US$ 635 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-03-12
Pages: 72
USD 2900.00
(Single User License)
Global and Japan Canine Tumor Screening Market Report & Forecast 2024-2030
The global Canine Tumor Screening revenue was US$ 397 million in 2023 and is forecast to a readjusted size of US$ 600 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published Date: 2024-12-12
Pages: 93
USD 4350.00
(Single User License)
Canine Tumor Screening- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Canine Tumor Screening was estimated to be worth US$ 397 million in 2023 and is forecast to a readjusted size of US$ 600 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030.
Published Date: 2024-12-12
Pages: 96
USD 3950.00
(Single User License)
Global Canine Tumor Screening Market Insights, Forecast to 2030
Valued at US$ 411 million in 2024, the global Canine Tumor Screening market is forecast to reach US$ 600 million by 2030, at a CAGR of 6.5% during the forecast period.
Published Date: 2024-12-12
Pages: 128
USD 4900.00
(Single User License)
Global Canine Tumor Screening Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Canine Tumor Screening market is projected to grow from US$ 435 million in 2025 to US$ 672 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 120
USD 4900.00 (Single User License)Global Canine Tumor Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Canine Tumor Screening market size was US$ 435 million in 2025 and is forecast to reach a readjusted size of US$ 672 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 80
USD 4250.00 (Single User License)Global Canine Tumor Screening Market Research Report 2026
The global Canine Tumor Screening market was valued at US$ 435 million in 2025 and is anticipated to reach US$ 672 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 104
USD 2900.00 (Single User License)Canine Tumor Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Canine Tumor Screening was estimated to be worth US$ 435 million in 2025 and is projected to reach US$ 672 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 97
USD 3950.00 (Single User License)Global Canine Tumor Screening Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Canine Tumor Screening market is projected to grow from US$ 411 million in 2024 to US$ 635 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 127
USD 4900.00 (Single User License)Canine Tumor Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Canine Tumor Screening was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 635 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 97
USD 3950.00 (Single User License)Global Canine Tumor Screening Market Research Report 2025
The global market for Canine Tumor Screening was valued at US$ 411 million in the year 2024 and is projected to reach a revised size of US$ 635 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-03-12
Pages: 72
USD 2900.00 (Single User License)Global and Japan Canine Tumor Screening Market Report & Forecast 2024-2030
The global Canine Tumor Screening revenue was US$ 397 million in 2023 and is forecast to a readjusted size of US$ 600 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published: 2024-12-12
Pages: 93
USD 4350.00 (Single User License)Canine Tumor Screening- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Canine Tumor Screening was estimated to be worth US$ 397 million in 2023 and is forecast to a readjusted size of US$ 600 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030.
Published: 2024-12-12
Pages: 96
USD 3950.00 (Single User License)Global Canine Tumor Screening Market Insights, Forecast to 2030
Valued at US$ 411 million in 2024, the global Canine Tumor Screening market is forecast to reach US$ 600 million by 2030, at a CAGR of 6.5% during the forecast period.
Published: 2024-12-12
Pages: 128
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now